Kura Oncology to Showcase Innovations at Virtual Conference

Author: Logan Wright Updated: 09-24-2025 08:01 AM

Kura Oncology's Upcoming Participation in Investor Conference

Kura Oncology, Inc. (Nasdaq: KURA), a dynamic clinical-stage biopharmaceutical company focused on innovative cancer treatments, has announced its participation in an important upcoming investor conference. This event will provide a platform for Kura's management to highlight the company's advances in precision medicine for cancer therapies.

Details of the UBS Virtual Oncology Day

Scheduled for October 1, the UBS Virtual Oncology Day will facilitate discussions about the latest developments in oncology. This virtual conference will start at 2:30 p.m. ET / 11:30 a.m. PT, allowing investors to engage with Kura's leadership.

How to Access the Presentation

Investors interested in the event can tune in to a live audio webcast available through the Investors section of Kura Oncology's website. A recorded version will also be accessible afterward, ensuring stakeholders have the opportunity to catch up on the vital information shared.

Understanding Kura Oncology’s Mission

Kura Oncology is dedicated to transforming cancer care through precision medicine. Their pipeline includes advanced drug candidates that target specific cancer pathways, aimed at fulfilling high unmet needs in hematologic malignancies and solid tumors, reinforcing their commitment to changing cancer treatment paradigms.

Innovations in Cancer Treatments

Focusing on the development of ziftomenib, a menin inhibitor, Kura Oncology addresses genetic drivers specifically associated with acute myeloid leukemia. The company is also innovating further in areas of farnesyl transferase inhibition, looking to combat mechanisms that contribute to adaptive and innate drug resistance in solid tumors.

Staying Connected with Kura Oncology

For further insights into Kura Oncology’s research and initiatives, the company invites you to visit their official website and follow their updates on social media platforms such as X and LinkedIn. This engagement helps in keeping stakeholders informed about Kura's journey and significant milestones in oncology.

Contact Information for Investors and Media

For inquiries, Greg Mann, a key contact at Kura Oncology, is available for investors and media representatives. He can be reached at 858-987-4046 or via email to discuss any investment-related questions or requests for additional information.

Frequently Asked Questions

What does Kura Oncology specialize in?

Kura Oncology specializes in developing targeted therapies for cancer, focusing on precision medicine to enhance treatment efficacy.

When will Kura Oncology participate in the investor conference?

Kura Oncology's management is scheduled to participate in the UBS Virtual Oncology Day on October 1, starting at 2:30 p.m. ET.

How can I watch the Kura Oncology presentation?

Interested viewers can access a live audio webcast of the presentation through Kura's Investor Relations section on their website, with a replay available afterward.

What are the current developments in Kura's pipeline?

Currently, Kura Oncology is advancing its drug candidate ziftomenib while exploring innovative strategies in cancer treatment targeting resistance mechanisms.

How can I contact Kura Oncology for more information?

Investors and media can reach Greg Mann at 858-987-4046 or via email to address queries regarding the company's developments and investor relations.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.